- Report
- January 2024
- 156 Pages
Global
From €3596EUR$3,783USD£3,084GBP
€4230EUR$4,450USD£3,629GBP
- Report
- November 2020
- 248 Pages
Asia Pacific
From €4706EUR$4,950USD£4,036GBP
- Report
- March 2021
- 248 Pages
Global
From €4706EUR$4,950USD£4,036GBP
- Report
- April 2023
- 200 Pages
Global
From €5656EUR$5,950USD£4,852GBP
- Report
- October 2023
- 101 Pages
Global
From €3500EUR$3,944USD£3,107GBP
- Report
- May 2021
- 100 Pages
Global
From €3200EUR$3,606USD£2,841GBP
- Book
- October 2013
- 701 Pages
The Animal Antimicrobials market is a segment of the Animal Healthcare/Veterinary industry that focuses on the development and sale of antimicrobial drugs for animals. These drugs are used to treat and prevent bacterial, fungal, and viral infections in animals. They are also used to treat and prevent diseases caused by parasites. Animal antimicrobials are available in various forms, such as tablets, capsules, injections, and topical solutions.
The Animal Antimicrobials market is driven by the increasing prevalence of animal diseases, the growing demand for pet healthcare, and the rising awareness of animal health among pet owners. Additionally, the increasing demand for animal-derived food products is also driving the market.
The Animal Antimicrobials market is highly competitive, with a number of large and small companies operating in the space. Some of the major players in the market include Bayer AG, Merck & Co., Inc., Zoetis, Inc., Elanco Animal Health, Inc., and Virbac SA. Show Less Read more
